Marinus Pharmaceuticals Inc (STU:61Y)
€ 1.61 0.12 (8.05%) Market Cap: 88.85 Mil Enterprise Value: 82.45 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 36/100

Marinus Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 15, 2020 / 05:15PM GMT
Release Date Price: €11.36 (+57.78%)
Rahul D Sood;Morgan Stanley;Senior Consultant

Scott and Ed, welcome to the Morgan Stanley Conference. Good to see you guys here and appreciate your time.

Scott Braunstein
Marinus Pharmaceuticals, Inc. - CEO & President

Thanks, Rahul. Appreciate you taking the time to lead this session.

Rahul D Sood;Morgan Stanley;Senior Consultant

No, of course, and a little bit of a strange time these days, given this is all virtual. But before we begin, I would point everyone who is attending today's session to go to Morgan Stanley -- to review Morgan Stanley's research disclosure by going to our website and taking a look at it.

Questions & Answers

Rahul D Sood;Morgan Stanley;Senior Consultant

So with that, Scott, you guys are on a -- you guys are on a bit of a roll here with the Marigold Study announcement for the CDKL5 that -- the data that was released yesterday. Why don't we just start

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot